Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Berk, MD
Arcutis Biotherapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arcutis Biotherapeutics Clinical Site 35
Calgary, Alberta, Canada
- Arcutis Biotherapeutics Clinical Site 37
Surrey, British Columbia, Canada
- Arcutis Biotherapeutics Clinical Site 47
Winnepeg, Manitoba, Canada
- Arcutis Biotherapeutics Clinical Site 43
Fredericton, New Brunswick, Canada
- Arcutis Biotherapeutics Clinical Site 38
Ajax, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 16
London, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 29
Mississauga, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 30
North Bay, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 32
Peterborough, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 71
Toronto, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 36
Waterloo, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 49
Windsor, Ontario, Canada
- Arcutis Biotherapeutics Clinical Site 09
Montreal, Quebec, Canada
- Arcutis Biotherapeutics Clinical Site 01
Scottsdale, Arizona, United States
- Arcutis Biotherapeutics Clinical Site 50
Beverly Hills, California, United States
- Arcutis Biotherapeutics Clinical Site 45
Encinitas, California, United States
- Arcutis Biotherapeutics Clinical Site 64
San Diego, California, United States
- Arcutis Biotherapeutics Clinical Site 72
Santa Ana, California, United States
- Arcutis Biotherapeutics Clinical Site 21
Santa Monica, California, United States
- Arcutis Biotherapeutics Clinical Site 33
Clearwater, Florida, United States
- Arcutis Biotherapeutics Clinical Site 42
Coral Gables, Florida, United States
- Arcutis Biotherapeutics Clinical Site 57
Delray Beach, Florida, United States
- Arcutis Biotherapeutics Clinical Site 31
North Miami Beach, Florida, United States
- Arcutis Biotherapeutics Clinical Site 05
Orlando, Florida, United States
- Arcutis Biotherapeutics Clinical Site 65
Sanford, Florida, United States
- Arcutis Biotherapeutics Clinical Site 12
Tampa, Florida, United States
- Arcutis Biotherapeutics Clinical Site 22
Plainfield, Illinois, United States
- Arcutis Biotherapeutics Clinical Site 10
Rolling Meadows, Illinois, United States
- Arcutis Biotherapeutics Clinical Site 15
Louisville, Kentucky, United States
- Arcutis Biotherapeutics Clinical Site 04
Lake Charles, Louisiana, United States
- Arcutis Biotherapeutics Clinical Site 02
Rockville, Maryland, United States
- Arcutis Biotherapeutics Clinical Site 28
Rockville, Maryland, United States
- Arcutis Biotherapeutics Clinical Site 20
Detroit, Michigan, United States
- Arcutis Biotherapeutics Clinical Site 14
New Brighton, Minnesota, United States
- Arcutis Biotherapeutics Clinical Site 44
Saint Joseph, Missouri, United States
- Arcutis Biotherapeutics Clinical Site 34
East Windsor, New Jersey, United States
- Arcutis Biotherapeutics Clinical Site 51
Rochester, New York, United States
- Arcutis Biotherapeutics Clinical Site 63
The Bronx, New York, United States
- Arcutis Biotherapeutics Clinical Site 23
High Point, North Carolina, United States
- Arcutis Biotherapeutics Clinical Site 25
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Aug 2021
- Primary completion
- 3 Jun 2022
- Completion
- 3 Jun 2022
- Last update posted
- 17 Jul 2025
- Registered enrollment
- 432
- Registry id
- NCT05028582
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.